CASI Pharmaceuticals
CASI
CASI
51 hedge funds and large institutions have $22.4M invested in CASI Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
51% less capital invested
Capital invested by funds: $46M → $22.4M (-$23.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$758K | |
| 2 | +$289K | |
| 3 | +$239K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$214K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$157K |
Top Sellers
| 1 | -$1.86M | |
| 2 | -$774K | |
| 3 | -$553K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$523K |
| 5 |
Millennium Management
New York
|
-$346K |